Literature DB >> 7907196

Molecular analysis of the glycoprotein C-negative phenotype of attenuated Marek's disease virus.

M R Wilson1, R A Southwick, J T Pulaski, V L Tieber, Y Hong, P M Coussens.   

Abstract

Serial passage of oncogenic serotype 1 Marek's Disease virus (MDV) in cultured avian cells results in attenuation of viral oncogenicity and pathogenicity. Coincident with attenuation, expression of MDV glycoprotein C (gC) is significantly reduced. Regulation of MDV gC may have important implications for virus-host interactions and have important consequences in the process of viral attenuation. To investigate the mechanism by which MDV gC expression is reduced during attenuation of the very virulent serotype 1 MDV strain Md11, protein levels, gene structure, steady-state RNA levels, and transcription rates of MDV gC from oncogenic and attenuated isolates of Md11 were determined. Comparison of these data with similar studies on MDV proteins whose expression is not altered during attenuation indicates that reduced expression of MDV gC is directly related to reduction in transcription rate of the MDV gC gene in attenuated Md11. Reduced transcription rates and lack of any gross structural alterations in the attenuated MDV gC gene suggest that MDV regulatory protein(s) which interact with the MDV gC promoter are altered during attenuation of MDV strain Md11. This conclusion is supported by DNA sequence data which indicate that the promoters of oncogenic and attenuated Md11 gC genes are identical.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7907196     DOI: 10.1006/viro.1994.1137

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Marek's disease virus expresses multiple UL44 (gC) variants through mRNA splicing that are all required for efficient horizontal transmission.

Authors:  Keith W Jarosinski; Nikolaus Osterrieder
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

2.  Attenuation of Marek's disease virus by deletion of open reading frame RLORF4 but not RLORF5a.

Authors:  Keith W Jarosinski; Nikolaus Osterrieder; Venugopal K Nair; Karel A Schat
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 3.  The Leeuwenhoek Lecture, 1997. Marek's disease herpesvirus: oncogenesis and prevention.

Authors:  P M Biggs
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-12-29       Impact factor: 6.237

4.  High-level expression of Marek's disease virus glycoprotein C is detrimental to virus growth in vitro.

Authors:  B Karsten Tischer; Daniel Schumacher; Danièlle Chabanne-Vautherot; Vladimir Zelnik; Jean-François Vautherot; Nikolaus Osterrieder
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

5.  Identification of an immediate-early gene in the Marek's disease virus long internal repeat region which encodes a unique 14-kilodalton polypeptide.

Authors:  Y Hong; P M Coussens
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

6.  Alterations of the MDV oncogenic regions in an MDV transformed lymphoblastoid cell line.

Authors:  E Le Rouzic; P Thoraval; M Afanassieff; Y Cherel; G Dambrine; B Perbal
Journal:  Mol Pathol       Date:  2002-08

7.  Newly detected mutations in the Meq oncogene and molecular pathotyping of very virulent Marek's disease herpesvirus in Tunisia.

Authors:  Jihene Lachheb; Houssem Mastour; Jihene Nsiri; Khaled Kaboudi; Imed Choura; Faten Ammouna; Abdelkader Amara; Abdeljelil Ghram
Journal:  Arch Virol       Date:  2020-09-02       Impact factor: 2.574

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.